Edge Biologicals, Inc.

Edge Biologicals, Inc. specializes in single-use medical devices primarily for laboratory applications. Their portfolio includes tissue culture and microbiology petri dishes, which are used for growing cells or microorganisms in controlled environments. They also produce basic nutrient broth culture media classified as in vitro diagnostic (IVD) devices, designed for microbiological testing. These products support research, clinical diagnostics, and quality control workflows.

Edge Biologicals, Inc. is based in the United States, which means its devices fall under U.S. regulatory frameworks like the FDA. The company’s products are listed in the FDA’s 510(k) premarket notification database and include Unique Device Identifiers (UDIs), indicating compliance with U.S. requirements for tracking and classification. The regulatory classification (Class I or Class II) determines the level of oversight, with Class II devices requiring more stringent documentation and validation.

Edge Biologicals, Inc.’s devices are documented in the FDA’s 510(k) premarket notification database, which records submissions for Class II devices requiring pre-market clearance. Additionally, their products are assigned Unique Device Identifiers (UDIs), ensuring traceability and compliance with FDA’s UDI System. These listings reflect the company’s adherence to U.S. regulatory requirements for medical devices.

Edge Biologicals, Inc.’s devices are classified under FDA’s Class I or Class II categories. Class I devices generally pose minimal risk and require less regulatory scrutiny, while Class II devices involve moderate risk and require pre-market notifications (like 510(k)s) to demonstrate substantial equivalence to existing devices. The classification depends on factors like intended use, potential harm, and the level of regulatory control needed to ensure safety and effectiveness.